MRI与CT在介入治疗肝癌后癌肿残留及复发的早期诊断应用  

Research on the application of MRI and CT in the early diagnosis of liver cancer after interventional therapy

作　　者：马立华 么旺 

机构地区：[1]辽宁电力中心医院医学影像科,沈阳辽宁110006

出　　处：《中西医结合肝病杂志》2017年第1期50-52,共3页Chinese Journal of Integrated Traditional and Western Medicine on Liver Diseases

摘　　要：目的:运用CT扫描及核磁共振成像(MRI)检查技术,对介入治疗后肝癌患者的检测结果进行对比分析,探讨MRI和CT成像技术在肝癌残留及复发病灶早期诊断方面的临床应用价值。方法:选取80例肝癌患者,分别进行CT扫描及MRI检查,并将其早期诊断结果与随访复查结果相比较。结果:MRI检查介入治疗后,患者肝癌残留及复发病灶准确率明显高于CT扫描(P<0.05)。结论:MRI扫描检查在介入治疗后,患者肝癌残留及复发病灶早期诊断方面具有更高的准确率。Objective：To discuss the application value of magnetic resonance imaging（MRI） and CT in the early diagnosis of liver cancer after interventional therapy. Methods：80 patients with hepatocellular carcinoma （HCC） were detected by CT scan and MRI respectively, and the early diagnosis and the follow-up resuhs were compared. Results： MRI accuracy rate was significantly higher than that of CT scanning （ P 〈 0.05 ）. Conclusion： MRI has a higher accuracy in the early diagnosis of hepatic cancer residue and recurrent lesions after interventional therapy.

关 键 词：CT扫描 核磁共振成像 肝癌残留 复发病灶 早期诊断 

分 类 号：R735.7[医药卫生—肿瘤] R730.44[医药卫生—临床医学] R445.2